Tesamorelin, a synthetic substance closely resembling human growth hormone-releasing hormone (hGH-RH ), is largely utilized in the management of HIV-associated lipodystrophy. The disorder involves reduction of subcutaneous tissue and increase of visceral deposits. While originally approved for this specific purpose, ongoing investigations are looki